Literature DB >> 22198169

Calsequestrin 2 and arrhythmias.

Michela Faggioni1, Björn C Knollmann.   

Abstract

Calsequestrin is the most abundant Ca-binding protein of the specialized endoplasmic reticulum found in muscle, the sarcoplasmic reticulum (SR). Calsequestrin binds Ca with high capacity and low affinity and importantly contributes to the mobilization of Ca during each contraction both in skeletal and cardiac muscle. Surprisingly, mutations in the gene encoding the cardiac isoform of calsequestrin (Casq2) have been associated with an inherited form of ventricular arrhythmia triggered by emotional or physical stress termed catecholaminergic polymorphic ventricular tachycardia (CPVT). Despite normal cardiac contractility and normal resting ECG, CPVT patients present with a high risk of sudden death at a young age. Here, we review recent new insights regarding the role of calsequestrin in genetic and acquired arrhythmia disorders. Mouse models of CPVT have shed light on the pathophysiological mechanism underlying CPVT. Casq2 is not only a Ca-storing protein as initially hypothesized, but it has a far more complex function in Ca handling and regulating SR Ca release channels. The functional importance of Casq2 interactions with other SR proteins and the importance of alterations in Casq2 trafficking are also being investigated. Reports of altered Casq2 trafficking in animal models of acquired heart diseases such as heart failure suggest that Casq2 may contribute to arrhythmia risk beyond genetic forms of Casq2 dysfunction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22198169      PMCID: PMC3311477          DOI: 10.1152/ajpheart.00779.2011

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  110 in total

1.  T-tubule profiles in Purkinje fibres of mammalian myocardium.

Authors:  Alessandro Di Maio; H E Ter Keurs; Clara Franzini-Armstrong
Journal:  J Muscle Res Cell Motil       Date:  2007-06-16       Impact factor: 2.698

Review 2.  Mechanisms of arrythmogenic cardiac alternans.

Authors:  Lance D Wilson; David S Rosenbaum
Journal:  Europace       Date:  2007-11       Impact factor: 5.214

3.  Characterization of human cardiac calsequestrin and its deleterious mutants.

Authors:  Eunjung Kim; Buhyun Youn; Lenord Kemper; Cait Campbell; Hendrik Milting; Magdolna Varsanyi; ChulHee Kang
Journal:  J Mol Biol       Date:  2007-08-29       Impact factor: 5.469

4.  On the role of junctin in cardiac Ca2+ handling, contractility, and heart failure.

Authors:  Ulrich Gergs; Tobias Berndt; Jan Buskase; Larry R Jones; Uwe Kirchhefer; Frank U Müller; Klaus-Dieter Schlüter; Wilhelm Schmitz; Joachim Neumann
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-03-30       Impact factor: 4.733

5.  Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia.

Authors:  Rafael Rosso; Jonathan M Kalman; Ori Rogowski; Shmuel Diamant; Amir Birger; Simon Biner; Bernard Belhassen; Sami Viskin
Journal:  Heart Rhythm       Date:  2007-05-24       Impact factor: 6.343

6.  Protein protein interactions between triadin and calsequestrin are involved in modulation of sarcoplasmic reticulum calcium release in cardiac myocytes.

Authors:  Dmitry Terentyev; Serge Viatchenko-Karpinski; Srikanth Vedamoorthyrao; Sridhar Oduru; Inna Györke; Simon C Williams; Sandor Györke
Journal:  J Physiol       Date:  2007-06-14       Impact factor: 5.182

7.  Modest reductions of cardiac calsequestrin increase sarcoplasmic reticulum Ca2+ leak independent of luminal Ca2+ and trigger ventricular arrhythmias in mice.

Authors:  Nagesh Chopra; Prince J Kannankeril; Tao Yang; Thinn Hlaing; Izabela Holinstat; Kristen Ettensohn; Karl Pfeifer; Brandy Akin; Larry R Jones; Clara Franzini-Armstrong; Björn C Knollmann
Journal:  Circ Res       Date:  2007-07-26       Impact factor: 17.367

8.  A mutation in calsequestrin, CASQ2D307H, impairs Sarcoplasmic Reticulum Ca2+ handling and causes complex ventricular arrhythmias in mice.

Authors:  Wessel P Dirksen; Veronique A Lacombe; Mei Chi; Anuradha Kalyanasundaram; Serge Viatchenko-Karpinski; Dmitry Terentyev; Zhixiang Zhou; Srikanth Vedamoorthyrao; Ning Li; Nipavan Chiamvimonvat; Cynthia A Carnes; Clara Franzini-Armstrong; Sandor Györke; Muthu Periasamy
Journal:  Cardiovasc Res       Date:  2007-03-12       Impact factor: 10.787

9.  Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia.

Authors:  Lei Song; Ronny Alcalai; Michael Arad; Cordula M Wolf; Okan Toka; David A Conner; Charles I Berul; Michael Eldar; Christine E Seidman; J G Seidman
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

10.  Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia.

Authors:  Marina Cerrone; Sami F Noujaim; Elena G Tolkacheva; Arkadzi Talkachou; Ryan O'Connell; Omer Berenfeld; Justus Anumonwo; Sandeep V Pandit; Karen Vikstrom; Carlo Napolitano; Silvia G Priori; José Jalife
Journal:  Circ Res       Date:  2007-09-13       Impact factor: 17.367

View more
  34 in total

1.  Calsequestrin depolymerizes when calcium is depleted in the sarcoplasmic reticulum of working muscle.

Authors:  Carlo Manno; Lourdes C Figueroa; Dirk Gillespie; Robert Fitts; ChulHee Kang; Clara Franzini-Armstrong; Eduardo Rios
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-09       Impact factor: 11.205

2.  Dynamic measurement of the calcium buffering properties of the sarcoplasmic reticulum in mouse skeletal muscle.

Authors:  Carlo Manno; Monika Sztretye; Lourdes Figueroa; Paul D Allen; Eduardo Ríos
Journal:  J Physiol       Date:  2012-11-12       Impact factor: 5.182

Review 3.  Functional interaction between calsequestrin and ryanodine receptor in the heart.

Authors:  Marta Gaburjakova; Naresh C Bal; Jana Gaburjakova; Muthu Periasamy
Journal:  Cell Mol Life Sci       Date:  2012-10-30       Impact factor: 9.261

Review 4.  Alterations in T-tubule and dyad structure in heart disease: challenges and opportunities for computational analyses.

Authors:  Eva Poláková; Eric A Sobie
Journal:  Cardiovasc Res       Date:  2013-02-07       Impact factor: 10.787

5.  Clinical utility gene card for: Catecholaminergic polymorphic ventricular tachycardia (CPVT).

Authors:  Carlo Napolitano; Raffaella Bloise; Mirella Memmi; Silvia Giuliana Priori
Journal:  Eur J Hum Genet       Date:  2013-04-03       Impact factor: 4.246

Review 6.  Mouse models of arrhythmogenic cardiovascular disease: challenges and opportunities.

Authors:  Jeanne M Nerbonne
Journal:  Curr Opin Pharmacol       Date:  2014-03-13       Impact factor: 5.547

7.  Association of CASQ2 polymorphisms with sudden cardiac arrest and heart failure in patients with coronary artery disease.

Authors:  Marwan M Refaat; Bradley E Aouizerat; Clive R Pullinger; Mary Malloy; John Kane; Zian H Tseng
Journal:  Heart Rhythm       Date:  2014-01-17       Impact factor: 6.343

8.  Altered calcium handling produces reentry-promoting action potential alternans in atrial fibrillation-remodeled hearts.

Authors:  Tao Liu; Feng Xiong; Xiao-Yan Qi; Jiening Xiao; Louis Villeneuve; Issam Abu-Taha; Dobromir Dobrev; Congxin Huang; Stanley Nattel
Journal:  JCI Insight       Date:  2020-04-07

9.  Calsequestrin 2 deletion causes sinoatrial node dysfunction and atrial arrhythmias associated with altered sarcoplasmic reticulum calcium cycling and degenerative fibrosis within the mouse atrial pacemaker complex1.

Authors:  Alexey V Glukhov; Anuradha Kalyanasundaram; Qing Lou; Lori T Hage; Brian J Hansen; Andriy E Belevych; Peter J Mohler; Björn C Knollmann; Muthu Periasamy; Sandor Györke; Vadim V Fedorov
Journal:  Eur Heart J       Date:  2013-11-11       Impact factor: 29.983

Review 10.  Molecular and genetic basis of sudden cardiac death.

Authors:  Alfred L George
Journal:  J Clin Invest       Date:  2013-01-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.